Akebia Therapeutics | AKBA - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Acadia Pharmaceuticals USD 851.46M 31.77M 2026-03
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Akebia Therapeutics USD 162.64M 22.2M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amgen USD 12.04B 2.91B 2026-03
Ardelyx USD 31.21M 36.79M 2026-03
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 7.56B 1.85B 2026-03
Bayer EUR 6.67B 774M 2025-12
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Celltrion KRW 49.87B 20.22B 2025-12
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Exelixis USD 226.15M 256.34M 2026-03
Fresenius Medical Care EUR 1.24B 343.37M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Ironwood Pharmaceuticals USD 220.47M 5.01M 2026-03
J&J USD 21.69B 1.98B 2026-03
Kangmei Pharma CNY 1.18B 278M 2025-09
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Lexicon Pharmaceuticals USD 38.09M 3.76M 2026-03
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 1.91B 687M 2026-03
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pharma Mar EUR 48.86M 31.05M 2026-03
Prothena USD 329.46M 21.93M 2026-03
PTC Therapeutics USD 833.99M 150.66M 2026-03
Qiagen NV USD 839M 516.58M 2025-12
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Tilray USD 264.83M 43.16M 2025-06
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03